Moxetumomab pasudotox and Mycophenolate Tablets Delayed Release
Determining the interaction of Moxetumomab pasudotox and Mycophenolate Tablets Delayed Release and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: mycophenolic acid
Brand name: Myfortic
Synonyms: Mycophenolic acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Mycophenolic acid
- Moxetumomab pasudotox-Mycophenolic Acid Delayed-Release Tablets
- Moxetumomab pasudotox-Mycophenolic Acid Tablets
- Moxetumomab pasudotox-Mycostatin (Nystatin Oral Suspension)
- Moxetumomab pasudotox-Mycostatin (Nystatin Tablets and Capsules)
- Moxetumomab pasudotox-Mycostatin Suspension
- Mycophenolate Tablets Delayed Release-Moxetumomab Pasudotox-tdfk
- Mycophenolate Tablets Delayed Release-Moxetumomab pasudotox-tdfk Intravenous
- Mycophenolate Tablets Delayed Release-Moxifloxacin
- Mycophenolate Tablets Delayed Release-Moxifloxacin (Systemic)
- Mycophenolate Tablets Delayed Release-Moxifloxacin Hydrochloride
- Mycophenolate Tablets Delayed Release-Moxifloxacin Injection